This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Katsuyama, K. Articles by Hirata, Y. Search for Related Content PubMed PubMed Citation Articles by Katsuyama, K. Articles by Hirata, Y.

Role of Nuclear Factor-B Activation in Cytokine- and Sphingomyelinase-Stimulated Inducible Nitric Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells¹

Endocrine-Hypertension Division, Second Department of Internal Medicine, Tokyo Medical and Dental University, Tokyo 113, Japan

Address all correspondence and requests for reprints to: Yukio Hirata, M.D., Endocrine-Hypertension Division, Second Department of Internal Medicine, Tokyo Medical and Dental University, 1–5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion Note Added in Proof References

 
Inflammatory cytokines, such as interleukin-1ß (IL-1ß) and tumor necrosis factor- (TNF), are known to activate sphingomyelinase (SMase) and nuclear factor-B (NF-B) in certain cell types, which also stimulate inducible nitric oxide synthase (iNOS) gene in vascular smooth muscle cells (VSMCs). However, it remains unknown whether the SMase pathway is involved in iNOS gene expression in VSMCs. Therefore, the present study was designed to examine whether SMase induces iNOS gene expression via the NF-B activation pathway similar to that of IL-1ß and TNF in cultured rat VSMCs. Neutral SMase, although less potently than IL-1ß and TNF, stimulated nitrite/nitrate (NOx) production, and iNOS messenger RNA and protein expression, as assessed by Northern and Western blot analyses, respectively. Neutral SMase, IL-1ß, and TNF activated NF-B, as revealed by electrophoretic mobility shift assay, and its nuclear translocation, as demonstrated by immunocytochemical study. Neutral SMase potentiated NOx production, iNOS expression, and NF-B activation stimulated by TNF, but not by IL-1ß. Aldehyde peptide proteasome inhibitors completely blocked NOx production, iNOS expression, NF-B activation, and its nuclear translocation induced by cytokines and neutral SMase. IL-1ß and TNF, but not neutral SMase, caused a transient decrease in IB- protein levels, whereas IB-ß protein expression was not affected by either agent. Proteasome inhibitors prevented cytokine-mediated IB- degradation. Several cell-permeable ceramide analogs (C2, C6, and C8), hydrolysis products of sphingomyelin, activated NF-B less potently than neutral SMase, but had no effect on NOx production. These results demonstrate an essential role of NF-B activation in mediation of neutral SMase-induced iNOS expression, but distinct from the proteasome-mediated IB- degradation by cytokines, suggesting the possible involvement of an additional signaling pathway(s).

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion Note Added in Proof References

 
NITRIC oxide (NO), synthesized from L-arginine by NO synthases (NOS), possesses diverse physiological properties, such as vasodilation, neurotransmission, and mediation of immune responses (1). Three distinct isozymes have been identified to date. Two constitutive isozymes dominantly expressed in brain (NOS1) and endothelium (NOS3) are Ca²⁺/calmodulin dependent. Cytokine-inducible isozyme (iNOS2) is Ca²⁺ independent and produces excess amounts of NO by bacterial lipopolysaccharides (LPS) and certain cytokines in a variety of cells, including vascular smooth muscle cells (VSMCs).

VSMCs do not produce NO under normal conditions. However, after stimulation with LPS and certain cytokines, such as interleukin-1ß (IL-1ß) and tumor necrosis factor- (TNF), augmented iNOS expression causes excessive NO production, thereby leading to a profound and intractable hypotension, i.e. endotoxic shock. As VSMCs play a pivotal role in the regulation of vascular tonus, elucidation of iNOS gene regulation in VSMCs is critical for understanding the pathogenesis of endotoxic shock. Recent studies have suggested that iNOS gene expression has also been implicated in the pathogenesis of vascular remodeling and atherosclerosis (2), because excess NO production by iNOS in the blood vessels causes inhibition of cell proliferation and apoptosis of VSMCs (3, 4).

Nuclear factor-B (NF-B) is a heterodimeric complex, usually consisting of p50 and p65 (RelA) subunits, and functions as a pleiotropic regulator of many genes modulating immunological and inflammatory processes (5). p50/p65 heterodimer associates with IB to form an inactive cytoplasmic ternary complex. p65 subunit may also associate with a precursor protein (p105) of p50 to form an inactive complex. Activation of NF-B by LPS or cytokines requires either the degradation of its cytoplasmic inhibitor, IB- (6), or proteolytic cleavage of p105 through the ubiquitin- proteasome pathway after phosphorylation (7). After degradation of IB-, an active heterodimer, NF-B translocates into the nucleus and activates gene expression. However, the degradative process of IB- in mediation of cytokine-stimulated iNOS gene expression in VSMCs remains unknown.

One of the pivotal signal transduction pathways by cytokines is a sequential activation of phosphatidylcholine- specific phospholipase C (PC-PLC) and acidic sphingomyelinase (SMase), causing hydrolysis of sphingomyelin to generate ceramide (8). Ceramide can trigger the activation of several transcription factors, including NF-B (9). By contrast, a functionally and topologically distinct neutral SMase in the plasma membrane also initiates the hydrolysis of sphingomyelin to generate ceramide, which, in turn, stimulates several proline-directed protein kinases, such as ceramide-activated protein (CAP) kinase and Jun N-terminal kinase (JNK) (10). However, it remains unknown whether the sphingomyelin/ceramide pathway is involved in iNOS gene expression.

These observations led us to examine 1) whether cytokine-induced iNOS gene expression in VSMCs is mediated by activation of NF-B via the ubiquitin-proteasome pathway, 2) whether SMase induces iNOS gene expression by activating NF-B in the same manner as cytokines, and 3) whether cytokines and SMase trigger degradation of IB- to translocate NF-B into the nucleus.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion Note Added in Proof References

 
Materials
Human recombinant IL-1ß was provided by Otsuka Pharmaceutical (Tokushima, Japan). Murine recombinant TNF was purchased from Life Technologies (Grand Island, NY); SDS and EDTA were obtained from Wako Pure Chemical (Osaka, Japan); neutral SMase (Bacillus cereus), N-acetyl-D-sphingosine (C2-ceramide), PC-PLC (Clostridium perfringens), phenylmethylsulfonylfluoride (PMSF), dithiothreitol (DTT), poly(dI-dC), and EGTA were obtained from Sigma Chemical Co. (St. Louis, MO), [-³²P]Deoxy (d)-CTP was purchased from Amersham International (Aylesbury, UK), dNTP and a Klenow fragment of DNA polymerase I were obtained from Takara Shuzo (Shiga, Japan), MG115 and MG132 were purchased from Peptide Institute, and N-hexanoylsphingosine (C6 ceramide) and N-octanoylsphingosine (C8 ceramide) were obtained from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA).

Cell culture
VSMCs from the thoracic aorta of 15-week-old male Wistar rats were prepared by the explant method and cultured in DMEM containing 10% FCS at 37 C in a humidified atmosphere of 95% air-5% CO₂ as described previously (11). Subcultured VSMCs (15–30th passages) were used in the experiments.

Determination of nitrite/nitrate (NOx)
Confluent VSMCs (10⁶ cells/well) preincubated with serum-free DMEM in the absence or presence of the indicated drugs for 30 min were stimulated with IL-1ß (10 ng/ml), TNF (100 ng/ml), or SMase (0.5–2 U/ml) for 15 h; NOx concentrations in the conditioned media were measured by an autoanalyzer (TCI-NOX 100, Tokyo Kasei Kogyo) as previously described (12). In brief, samples premixed with the carrier solution (0.07% EDTA and 0.3% NH₄Cl) was passed through a copperized cadmium reduction column to reduce NO₃^- to NO₂^-, which reacts with Griess reagent (1% sulfonamide, 0.1% N-1-naphtylethylenediamine dihydrochloride, and 5% HCl). Absorbance at 540 nm was measured by a flow-through visible spectrophotometer (model S/3250, Soma-Kogaku, Tokyo, Japan). NO3^- was used as a standard.

Electrophoretic mobility shift assay (EMSA)
After pretreatment with test compounds for 30 min, confluent cells (5 x 10⁶ cells/dish) were treated with IL-1ß (10 ng/ml), TNF (100 ng/ml), or SMase (1 U/ml) for 2 h; washed with ice-cold PBS; and harvested in 0.4 ml ice-cold hypotonic lysis buffer [10 mM HEPES (pH 7.8), 10 mM KCl, 2 mM MgCl₂, 1 mM DTT, 0.1 mM EDTA, 0.1 mM PMSF, and 5 µg/ml leupeptin]. After 15-min incubation, 25 µl 10% Nonidet P-40 were added and centrifuged at 10,000 x g for 1 min. The nuclei pellets were collected, resuspended in 30 µl hypertonic extraction buffer [50 mM HEPES (pH 7.8), 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 10% glycerol, and 0.1 mM PMSF], and centrifuged at 10,000 x g for 10 min, and the supernatant was subjected to EMSA. The single stranded oligonucleotides (forward, 5'-TGGGGACTCTCC-3'; complement, 5'-AAGGGAGAGTCC-3') corresponding to the NF-B-binding sequence of the downstream region (-107 to -97) of the rat iNOS gene promoter (13) were annealed at 65 C for 15 min and filled with [-³²P]dCTP (111 TBq/mmol), dNTP, and a Klenow fragment of DNA polymerase I. Nuclear proteins (10 µg) were incubated with 20,000 cpm ³²P-labeled NF-B double stranded oligonucleotide and 1 µg poly(dI-dC) in EMSA buffer [10 mM Tris-HCl (pH 7.5), 2% glycerol, 0.2 mM EDTA, 0.5 mM DTT, and 50 mM NaCl] for 30 min, loaded into a 5% polyacrylamide gel, and run in 50 mM Tris, 0.38 M glycine, and 2 mM EDTA, pH 8.5, at 150 V for 3 h. The gel was then dried and autoradiographed. To examine the specificity of the NF-B-binding protein, the gel shift assay was performed in parallel in the presence of a 100-fold excess of unlabeled oligonucleotide as a competitor. For supershift gel assay, nuclear protein was preincubated for 30 min with goat polyclonal antibodies against human NF-B p50 or p65 subunit (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) before EMSA.

Northern blot analysis
Confluent cells (5 x 10⁶ cells/dish) were stimulated with cytokines and/or SMase for 6 h, and total RNAs were extracted by the acid-guanidinium thiocyanate-phenol-chloroform method (14). Total RNAs (20 µg), separated by formaldehyde-1.1% agarose gel electrophoresis, were transferred to a Magna Graph nylon membrane (Micron Separations, Inc., Westboro, MA) that was hybridized with rat iNOS complementary DNA (15) labeled with [-³²P]dCTP (111 TBq/mmol) by the random primed labeling method, washed in 0.1 x SSPE(15 mM NaCl, 1 mM NaH₂PO₄, 0.1 mM EDTA)-0.5% SDS, autoradiographed.

Western blot analysis
Western blot analyses were performed essentially as previously described (16). Confluent cells (5 x 10⁶ cells/dish) were stimulated with cytokines and/or SMase for the indicated times for IB- and IB-ß or for 15 h for iNOS. After stimulation, cells were lysed in 50 mM Tris-HCl, pH 6.8 (10% glycerol, 1% SDS, 1 µg/ml pepstatin, 2 µg/ml leupeptin, 2 µg/ml aprotinin, and 1 mM PMSF). Whole cell lysates were boiled, and extracted proteins were separated on 12% (for IB- and IB-ß) or 7.5% (for iNOS) SDS-polyacrylamide gel and transferred to Hybond enhanced chemiluminescence nitrocellulose membranes (Amersham), which were incubated with either rabbit polyclonal antibody for human IB- (1:500) and IB-ß (1:500; Santa Cruz Biotechnology) or mouse monoclonal antibody for murine iNOS (1:1000; Transduction Laboratories, Inc., Lexington, KY) at 4 C overnight. After extensive washing, the secondary antibody (donkey antirabbit IgG or sheep antimouse Ig horseradish peroxidase; 1:500; Amersham) was incubated for 1 h, and exposure was performed using an enhanced chemiluminescence kit (Amersham).

Immunocytochemical staining
Subconfluent cells grown on Lab-Tek chamber slides (Nalge Nunc International, Chicago, IL) were treated with cytokines or SMase for 2 h and fixed with 70% acetone for 20 min at room temperature, then washed with PBS for 10 min. Goat polyclonal antibody specific for NF-B p50 subunit (Santa Cruz Biotechnology) was used; the antibody did not show any cross-reactivity with p105, p52, or p100. Immunostaining was visualized with the indirect immunoperoxidase avidin-biotin-peroxidase kit (Vector Laboratories, Inc., Burlingame, CA) as previously described (17).

Statistical analysis
All values are given as the mean ± SE. Statistical analysis was performed using Student’s t test. P < 0.05 was considered statistically significant.

	Results

Top Abstract Introduction Materials and Methods Results Discussion Note Added in Proof References

 
Cytokines stimulated NO production and iNOS expression via the NF-B pathway
We studied whether inhibition of NF-B activation by proteasome inhibitors affects NO production, iNOS messenger RNA (mRNA), and protein levels in rat VSMCs. As both IL-1ß (1–10 ng/ml) and TNF (10–100 ng/ml) dose dependently stimulated NOx production in rat VSMCs, we used the maximal concentrations of IL-1ß (10 ng/ml) and TNF (100 ng/ml) in subsequent experiments. As shown in Fig. 1, IL-1ß and TNF increased NOx production during 15-h incubation by 10- and 8-fold over that in control cells, respectively. These effects were suppressed with a proteasome inhibitor, MG115, in a dose-dependent fashion (0.5–10 µM); almost complete inhibition was induced with 5 µM (TNF) and 10 µM (IL-1ß), respectively. As the apparent K_i value of MG115 was 20 µM (7), and the maximal inhibition required to block IL-1ß-stimulated NOx production was 10–40 µM, we chose 40 µM MG115 in subsequent experiments. Neither cell viability nor cell morphology was affected by 40 µM. Both IL-1ß and TNF induced iNOS mRNA expression by Northern blot analysis (Fig 2, upper panel) and iNOS protein expression by Western blot analysis (Fig 2, middle panel); the effects of IL-1ß were greater than those of TNF. These effects were completely blocked with MG115 (40 µM).

View larger version (15K): [in this window] [in a new window]   Figure 1. Effect of proteasome inhibitor on cytokine-induced NO production in rat VSMCs. Confluent cells pretreated for 30 min with MG115 in the indicated concentrations were stimulated with IL-1ß (10 ng/ml) or TNF (100 ng/ml) for 15 h; concentrations of NOx released into media were measured. Each point represents the mean value (n = 3), and the SE is within each point.

View larger version (60K): [in this window] [in a new window]   Figure 2. Effect of proteasome inhibitor on cytokine-induced iNOS expression and NF-B activation in rat VSMCs. Confluent cells pretreated with (+) or without (-) MG115 (40 µM) for 30 min were stimulated with IL-1ß (10 ng/ml) or TNF (100 ng/ml) for 6 h for Northern blotting (upper panel) of iNOS mRNA (28S ribosomal RNA), for 15 h for Western blotting (middle panel) of 130-kDa iNOS protein, and for 2 h for EMSA (lower panel) of NF-B activity, respectively. A representative from two or three separate experiments is shown.

Neutral SMase, but not PC-PLC, stimulated NO production and iNOS expression via the NF-B pathway
To determine whether SMase directly affects iNOS gene expression in VSMCs, the effects of neutral SMase from bacterial origin on NOx production, iNOS mRNA and protein expression, and NF-B activation were examined. Neutral SMase dose dependently (0.5–2 U/ml) stimulated NOx production, whose effect was potentiated in the presence of TNF (100 ng/ml; Fig. 3), but not in the presence of IL-1ß (10 ng/ml; data not shown). SMase (1 U/ml) induced the expression of iNOS mRNA and protein, whose effects were similarly potentiated by the addition of TNF (100 ng/ml; Fig. 4, upper and middle panels), but not by IL-1ß (data not shown). SMase also induced activation of NF-B, which was similarly potentiated in the presence of TNF (Fig. 4, lower panel).

View larger version (14K): [in this window] [in a new window]   Figure 3. Effect of neutral SMase on TNF-induced NOx production in rat VSMCs. Confluent cells were stimulated with neutral SMase in the indicated concentrations in the presence () and absence () of TNF (100 ng/ml) for 15 h, and concentrations of NOx released into media were measured. Each column with bar represents the mean ± SE (n = 4).

View larger version (56K): [in this window] [in a new window]   Figure 4. Effects of neutral SMase on TNF-induced iNOS expression and NF-B activation in rat VSMCs. Confluent cells were stimulated with (+) or without (-) SMase (1 U/ml) in the presence (+) or absence (-) of TNF (100 ng/ml) for Northern blotting of iNOS mRNA (upper panel), Western blotting of iNOS protein (middle panel), and EMSA of NF-B activity (lower panel), respectively. A representative from two or three separate experiments is shown.

To determine whether activation of NF-B by neutral SMase is mediated via proteasome, we tested the effects of MG115 on SMase-induced NOx production, iNOS expression, and NF-B activation (Fig. 5). MG115 (40 µM) completely blocked NOx production (Fig. 5, left panel), expression of iNOS mRNA and protein, and NF-B activation (Fig. 5, right panel) stimulated by neutral SMase (1 U/ml). However, cell-permeable ceramide analogs (C2, C6, and C8; 100–500 µM) had no effect on NOx production; C2 ceramide (100–500 µM) caused NF-B activation far less potently than neutral SMase (data not shown).

View larger version (30K): [in this window] [in a new window]   Figure 5. Effects of proteasome inhibitor on neutral SMase-induced NOx production, iNOS expression, and NF-B activation in rat VSMCs. Confluent cells pretreated (A) with or without MG115 (40 µM) for 30 min were stimulated with neutral SMase (2 U/ml) at 37 C for NOx production, or (B) with neutral SMase (1 U/ml) for Northern blotting of iNOS mRNA (upper panel), for Western blotting of 130-kDa iNOS protein (middle panel), and for EMSA of NF-B activity (lower panel).

Cytokines and neutral SMase induced NF-B nuclear translocation

View larger version (106K): [in this window] [in a new window]   Figure 6. Effect of proteasome inhibitor on cytokine- and neutral SMase-induced nuclear translocation of NF-B by immunohistochemical staining. Cells pretreated with or without MG115 (40 µM) for 30 min were stimulated with IL-1ß (10 ng/ml), TNF (100 ng/ml), or neutral SMase (1 U/ml) for 2 h, fixed with 70% acetone, and stained with goat polyclonal antibody specific for the NF-B p50 subunit. A, Control; B, IL-1ß; C, TNF; D, SMase; E, MG115; F, IL-1ß plus MG115; G, TNF plus MG115; H, SMase plus MG115.

Cytokines, but not neutral SMase, induced IB- degradation

View larger version (39K): [in this window] [in a new window]   Figure 7. Effects of cytokines and neutral SMase on IB- and IB-ß expression in rat VSMCs. Confluent cells were incubated with IL-1ß (10 ng/ml), TNF (100 ng/ml), and SMase (1 U/ml) for the indicated times, and subjected to Western blot analysis using anti-IB- antibody (A) and anti-IB-ß antibody (B).

View larger version (54K): [in this window] [in a new window]   Figure 8. Effect of proteasome inhibitor on cytokine-induced IB degradation in rat VSMCs. Confluent cells pretreated with or without MG115 (40 µM) were stimulated with (A) IL-1ß (10 ng/ml) or (B) TNF (100 ng/ml) for 15 min and subjected to Western blot analysis using anti-IB- antibody.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion Note Added in Proof References

It has recently been demonstrated that the ubiquitin- proteasome pathway is required for NF-B activation by the degradation of IB- and/or by processing of the p105 precursor to p50 subunit after phosphorylation (7). Cell-permeable aldehyde peptide inhibitors have been shown to potently block TNF-induced degradation of IB- and activation of NF-B in Jurkat cells and HeLa cells (18, 19). In the present study, we have demonstrated that potent proteasome inhibitors (MG115 and MG132) completely blocked the degradation of IB- and the activation of NF-B induced by IL-1ß and TNF in rat VSMCs. These data are corroborated by the immunocytochemical study showing that MG115 prevented the nuclear translocation of p50 subunit induced by IL-1ß and TNF. The present study has clearly demonstrated that MG115 completely blocked the IL-1ß- and TNF-induced iNOS mRNA and protein expression and subsequent NO production in rat VSMCs. These results demonstrate for the first time that the proteasome-mediated degradation of IB- and subsequent NF-B activation are essential for the mechanism of cytokine-induced iNOS expression in rat VSMCs.

Recent evidence suggests that TNF and IL-1ß employ two sphingomyelin pathways to effect signal transduction by their receptors (10). One pathway is initiated by hydrolysis of plasma membrane sphingomyelin by neutral SMase and another by PC-PLC-mediated acidic SMase via diacylglycerol generation. Both neutral and acidic SMases generate ceramide, which serves as a second messenger to stimulate several protein kinases, such as CAP kinase and mitogen-activated protein (MAP) kinase. For example, it has been shown that TNF activates c-raf-1 kinase, which activates MAP kinase via neutral SMase (20), and that raf-1 induces NF-B activation (21).

Of particular interest in our study is that exogenous neutral SMase mimicked the effects of IL-1ß or TNF in rat VSMCs; neutral SMase activated NF-B and stimulated iNOS mRNA and protein expression and subsequent NO production. However, SMase alone was less effective than TNF in stimulating NO production, but was more effective in stimulating iNOS mRNA and protein expression and NF-B activation. The reasons for the apparent discrepancy between the effects of SMase and TNF remain unknown, but several possibilities could be speculated. First, this may be simply due to the different experimental conditions employed (incubation times, extraction procedures, etc.) and/or the stability of the final products measured. Second, the apparently lesser effect of TNF on NF-B activation and iNOS expression than on NO production may be secondary to the direct inhibition by massive NO generation on NF-B-DNA binding because NO donor has been shown to inhibit formation of the NF-B-DNA complex (22). Finally, the apparently lesser effect of SMase on NO production than on NF-B activation and iNOS expression may be consequent to the posttranslational modification of iNOS enzyme and/or cofactor availability resulting from phosphorylation by ceramide-mediated protein kinases.

It should be noted that the effects by neutral SMase were potentiated in the presence of TNF, but not of IL-1ß, and the effects of NF-B activation, iNOS mRNA and protein expression, and NO production induced by IL-1ß were consistently greater than those by TNF in rat VSMCs. These results suggest that the mechanisms involved in neutral SMase-induced NF-B activation and iNOS expression are similar, if not identical, to that of IL-1ß, but are distinct from that of TNF. IB-ß, another IB isoform that interacts with the same Rel protein dimers, displays distinct responses to NF-B inducers; TNF or phorbol ester causes a transient loss of IB- with a transient activation of NF-B, whereas IL-1 or LPS causes a transient loss of IB-, but persistent loss of IB-ß with continued activation of NF-B (23). Thus, the continued activation of NF-B in the absence of IB-ß may lead to the persistent expression of the genes induced by IL-1 and LPS. However, the present study did not show any changes in IB-ß protein expression by IL-1ß, TNF, or neutral SMase in rat VSMCs. Therefore, the possibility of different signaling pathways by cytokines and neutral SMase needs to be considered.

Initially, it has been suggested that activation of acidic SMase by cytokine-stimulated PC-PLC induces NF-B activation via ceramide (24, 25). However, recent studies have shown that TNF activates NF-B in fibroblasts derived from acidic SMase-deficient mice (26) and from patients with Niemann-Pick disease (27). In the present study, exogenous PC-PLC had no effect on NO production in rat VSMCs. Our results are in agreement with those of recent studies showing a limited role of the PC-PLC/acidic SMase/ceramide pathway in mediation of NF-B activation by cytokines in several cell types (28, 29, 30).

The present study has clearly demonstrated that NF-B activation and its nuclear translocation as well as the expression of iNOS mRNA and protein and subsequent NO production induced by neutral SMase were equally blocked by a proteasome inhibitor, MG115. It should be noted, however, that neutral SMase did not degrade IB-. These data are consistent with the idea that the effect of neutral SMase to induce NF-B activation is mediated through a mechanism other than IB- degradation, such as proteasome-mediated processing of p105. Taken together, it is suggested that neutral SMase partly shares a signaling pathway(s) in common with cytokines via the NF-B pathway, but distinct from the degradative process of IB-.

In this study, exogenous ceramide analogs caused NF-B activation far less potently than neutral SMase, but had no effect on NO production. These data suggest that ceramide plays some role in NF-B activation, but appears insufficient to induce full activation of NF-B-mediated iNOS expression. Similar dissociation of NF-B activation and cellular responses by ceramide and neutral SMase has been reported in other cell types. For example, ceramide and neutral SMase have been shown to be insufficient to induce NF-B activation, but enhance the cytokine-induced cytotoxic effect in T cells (31) and E-selectin expression in endothelial cells (32). Collectively, our data suggest that a signaling pathway(s) to NF-B activation by neutral SMase/ceramide is different from that of cytokines in rat VSMCs.

Recently, two closely related IB- kinases that directly phosphorylate IB- (33, 34, 35, 36, 37) as well as the upstream kinases, such as NF-B-inducing kinase (38) and a MAP kinase kinase kinase 1 (MEKK1) (39), have been identified that integrate IL-1- and TNF-induced NF-B activation (Fig. 9). However, an additional pathway(s) other than IB kinase-mediated phosphorylation by cytokines and SMase should be considered. In fact, it has been reported that TNF-induced E-selectin expression is activated by NF-B and the JNK/p38 MAP kinase family in endothelial cells (40). Furthermore, it has been shown that TNF phosphorylates not only IB-, but also p65 and p105, to induce DNA-binding activity in HeLa and B cells (41), and a novel serine/threonin kinase that activates NF-B by direct phosphorylation of p65 and p50 (NF-B kinase) has been identified (42). Thus, it is possible to speculate that cytokines (IL-1 and TNF) and SMase/ceramide, depending on cell type, may use multiple signaling pathways other than IB kinase-mediated phosphorylation of IB- to activate NF-B (Fig. 9).

View larger version (25K): [in this window] [in a new window]   Figure 9. Hypothetical model for NF-B activation pathways by cytokines and SMase in rat VSMCs. A major pathway is indicated by a bold line, and possible minor pathways are indicated by solid lines. TNFR-1, TNF receptor-1; IL-1R, IL-1 receptor, TRAF, TNFR-associated factor; NIK, NF-B-inducing kinase; nSMase, neutral sphingomyelinase; aSMase, acidic sphingomyelinase; DAG, diacylglycerol.

	Note Added in Proof

Top Abstract Introduction Materials and Methods Results Discussion Note Added in Proof References

 
During submission of our manuscript, Boland and O’Neil have reported that ceramide activates NF-ß in HL60 and Jurkat cells by inducing the processing of p105 with a marginal effect on Iß degradation, whereas TFN- stimulated both IB degradation and p105 processing (43).

	Footnotes

 
¹ This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture and the Ministry of Health and Welfare of Japan.

Received March 3, 1998.

	References

Top Abstract Introduction Materials and Methods Results Discussion Note Added in Proof References

 

1. Moncada S, Palmer R, Higgs E 1991 Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142[Medline]
2. Collins T 1993 Endothelial nuclear factor-B and the initiation of the atherosclerotic lesion. Lab Invest 68:499–508[Medline]
3. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM 1994 Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267:C1405–C1413
4. Fukuo K, Hata S, Suhara T, Nakahashi T, Shinto Y, Tsujimoto Y, Morimoto S, Ogihara T 1996 Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27:823–826[Abstract/Free Full Text]
5. Thanos D, Maniatis T 1995 NF-B: a lesson in family values. Cell 80:529–532[CrossRef][Medline]
6. Beg AA, Finco TS, Nantermet PV, Baldwin AJ 1993 Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IB-: a mechanism for NF-B activation. Mol Cell Biol 13:3301–3310[Abstract/Free Full Text]
7. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T 1994 The ubiquitin-proteasome pathway is required for processing the NF-B1 precursor protein and the activation of NF-B. Cell 78:773–785[CrossRef][Medline]
8. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M 1992 TNF activates NF-B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765–776[CrossRef][Medline]
9. Machleidt T, Wiegmann K, Henkel T, Schutze S, Baeuerle P, Kronke M 1994 Sphingomyelinase activates proteolytic IB- degradation in a cell-free system. J Biol Chem 269:13760–13765[Abstract/Free Full Text]
10. Kolesnick R, Golde DW 1994 The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325–328[CrossRef][Medline]
11. Hirata Y, Tomita M, Yoshimi H, Ikeda M 1984 Specific receptors for atrial natriuretic factor (ANF) in cultured vascular smooth muscle cells of rat aorta. Biochem Biophys Res Commun 125:562–568[CrossRef][Medline]
12. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F 1992 L-Arginine infusion induces hypotension and increases diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in human. Clin Exp Pharmacol Physiol 19:619–625[Medline]
13. Eberhardt W, Kunz D, Hummel R, Pfeilschifter J 1996 Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun 223:752–756[CrossRef][Medline]
14. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159[Medline]
15. Iwashina M, Hirata Y, Imai T, Sato K, Marumo F 1996 Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem 237:668–673[Medline]
16. Hanson KD, Shichiri M, Follansbee MR, Sedivy JM 1994 Effects of c-myc expression on cell cycle progression. Mol Cell Biol 14:5748–5755[Abstract/Free Full Text]
17. Tsujino M, Hirata Y, Imai T, Kanno K, Eguchi S, Ito H, Marumo F 1994 Induction of nitric oxide synthase gene by interleukin-1ß in cultured rat cardiocytes. Circulation 90:375–383[Abstract/Free Full Text]
18. Traenckner EB, Wilk S, Baeuerle PA 1994 A proteasome inhibitor prevents activation of NF-B and stabilizes a newly phosphorylated form of IB- that is still bound to NF-B. EMBO J 13:5433–5441[Medline]
19. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T 1995 Signal-induced site-specific phosphorylation targets IB- to the ubiquitin-proteasome pathway. Genes Dev 9:1586–1597[Abstract/Free Full Text]
20. Belka C, Wiegmann K, Adam D, Holland R, Neuloh M, Herrmann F, Kronke M, Brach MA 1995 Tumor necrosis factor (TNF)- activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J 14:1156–1165[Medline]
21. Li S, Sedivy JM 1993 Raf-1 protein kinase activates the NF-B transcription factor by dissociating the cytoplasmic NF-B-IB complex. Proc Natl Acad Sci USA 90:9247–9251[Abstract/Free Full Text]
22. Park SK, Lin HL, Murphy S 1997 Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-B binding to DNA. Biochem J 322:609–613
23. Thompson JE, Phillips RJ, Erdjument BH, Tempst P, Ghosh S 1995 IB-ß regulates the persistent response in a biphasic activation of NF-B. Cell 80:573–582[CrossRef][Medline]
24. Hannun YA 1994 The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125–3128[Free Full Text]
25. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M 1994 Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005–1015[CrossRef][Medline]
26. Zumbansen M, Stoffel W 1997 Tumor necrosis factor a activates NF-B in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J Biol Chem 272:10904–10909[Abstract/Free Full Text]
27. Kuno K, Sukegawa K, Ishikawa Y, Orii T, Matsushima K 1994 Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NF-B activation. Int Immunol 6:1269–1272[Abstract/Free Full Text]
28. Higuchi M, Singh S, Jaffrezou JP, Aggarwal BB 1996 Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-B activation. J Immunol 157:297–304[Abstract]
29. Johns LD, Sarr T, Ranges GE 1994 Inhibition of ceramide pathway does not affect ability of TNF- to activate nuclear factor-B. J Immunol 152:5877–5882[Abstract]
30. Slowik MR, De LL, Min W, Pober JS 1996 Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells. Circ Res 79:736–747[Abstract/Free Full Text]
31. Dbaibo GS, Obeid LM, Hannun YA 1993 Tumor necrosis factor- (TNF-) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF- from activation of nuclear factor-B. J Biol Chem 268:17762–17766[Abstract/Free Full Text]
32. Masamune A, Igarashi Y, Hakomori S 1996 Regulatory role of ceramide in interleukin (IL)-1ß-induced E-selectin expression in human umbilical vein endothelial cells. Ceramide enhances IL-1ß action, but is not sufficient for E-selectin expression. J Biol Chem 271:9368–9375[Abstract/Free Full Text]
33. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M 1997 A cytokine-responsive IB kinase that activates the transcription factor NF-B. Nature 388:548–554[CrossRef][Medline]
34. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A 1997 IKK-1 and IKK-2: cytokine-activated IB kinases essential for NF-B activation. Science 278:860–866[Abstract/Free Full Text]
35. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV 1997 IB kinase-ß: NF-B activation and complex formation with IB kinase- and NIK. Science 278:866–869[Abstract/Free Full Text]
36. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M 1997 The IB kinase complex (IKK) contains two kinase subunits, IKK and IKKß, necessary for IB phosphorylation and NF-B activation. Cell 91:243–252[CrossRef][Medline]
37. Regnier CH, Song HY, Gao X, Goeddel DV, Cao ZD, Rothe M 1997 Identification and characterization of an IB kinase. Cell 90:373–383[CrossRef][Medline]
38. Malinin NL, Boldin MP, Kovalenko AV, Wallach D 1997 MAP3K-related kinase involved in NF-B induction by TNF, CD95 and IL-1. Nature 385:540–544[CrossRef][Medline]
39. Lee FS, Hagler J, Chen ZJ, Maniatis T 1997 Activation of the IB- kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213–222[CrossRef][Medline]
40. Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, Collins T 1997 Tumor necrosis factor -induced E-selectin expression is activated by the nuclear factor-B and c-Jun N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 272:2753–2761[Abstract/Free Full Text]
41. Naumann M, Scheidereit C 1994 Activation of NF-B in vivo is regulated by multiple phosphorylations. EMBO J 13:4597–4607[Medline]
42. Hayashi T, Sekine T, Okamoto T 1993 Identification of a new serine kinase that activates NF-B by direct phosphorylation. J Biol Chem 268:26790–26795[Abstract/Free Full Text]
43. Boland MP, O’Neil LAJ 1998 Ceramide activates NF-ß by inducing the processing of p105. J Biol Chem 273:15494–15500[Abstract/Free Full Text]

This article has been cited by other articles:

				C. Shao, M. Folkard, B. D. Michael, and K. M. Prise Targeted cytoplasmic irradiation induces bystander responses PNAS, September 14, 2004; 101(37): 13495 - 13500. [Abstract] [Full Text] [PDF]

				M. Czarny, J. Liu, P. Oh, and J. E. Schnitzer Transient Mechanoactivation of Neutral Sphingomyelinase in Caveolae to Generate Ceramide J. Biol. Chem., February 7, 2003; 278(7): 4424 - 4430. [Abstract] [Full Text] [PDF]

				R. P. Cherla and R. K. Ganju Stromal Cell-Derived Factor 1{{alpha}}-Induced Chemotaxis in T Cells Is Mediated by Nitric Oxide Signaling Pathways J. Immunol., March 1, 2001; 166(5): 3067 - 3074. [Abstract] [Full Text] [PDF]

				R. H. UNGER and L. ORCI Diseases of liporegulation: new perspective on obesity and related disorders FASEB J, February 1, 2001; 15(2): 312 - 321. [Abstract] [Full Text] [PDF]

				M. Satoh, I. Date, M. Nakajima, K. Takahashi, K. Iseda, T. Tamiya, T. Ohmoto, Y. Ninomiya, S. Asari, and R. L. Macdonald Inhibition of Poly(ADP-Ribose) Polymerase Attenuates Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbits Editorial Comment Stroke, January 1, 2001; 32(1): 225 - 231. [Abstract] [Full Text] [PDF]

				L. R. Vann, S. Twitty, S. Spiegel, and S. Milstien Divergence in Regulation of Nitric-oxide Synthase and Its Cofactor Tetrahydrobiopterin by Tumor Necrosis Factor-alpha . CERAMIDE POTENTIATES NITRIC OXIDE SYNTHESIS WITHOUT AFFECTING GTP CYCLOHYDROLASE I ACTIVITY J. Biol. Chem., April 28, 2000; 275(18): 13275 - 13281. [Abstract] [Full Text] [PDF]

				T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S. Du Yan, M. Hofmann, S. F. Yan, M. Pischetsrieder, D. Stern, et al. Nepsilon -(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression J. Biol. Chem., October 29, 1999; 274(44): 31740 - 31749. [Abstract] [Full Text] [PDF]

				K. Katsuyama, M. Shichiri, H. Kato, T. Imai, F. Marumo, and Y. Hirata Differential Inhibitory Actions by Glucocorticoid and Aspirin on Cytokine-Induced Nitric Oxide Production in Vascular Smooth Muscle Cells Endocrinology, May 1, 1999; 140(5): 2183 - 2190. [Abstract] [Full Text]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this